Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease
dc.contributor.author | Wang, Min | |
dc.contributor.author | Gao, Mingzhang | |
dc.contributor.author | Xu, Zhidong | |
dc.contributor.author | Zheng, Qi-Huang | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | en_US |
dc.date.accessioned | 2017-11-09T17:39:11Z | |
dc.date.available | 2017-11-09T17:39:11Z | |
dc.date.issued | 2017-03 | |
dc.description.abstract | The reference standard (4-((5-chloro-4-(methylamino)pyrimidin-2-yl)amino)-3-methoxyphenyl)(morpholino)methanone (HG-10-102-01) and its precursor (4-((5-chloro-4-(methylamino)pyrimidin-2-yl)amino)-3-hydroxyphenyl)(morpholino)methanone (desmethyl-HG-10-102-01) were synthesized from 2,4,5-trichloropyrimide and 3-methoxy-4-nitrobenzoic acid with overall chemical yield 49% in four steps and 14% in five steps, respectively. The target tracer (4-((5-chloro-4-(methylamino)pyrimidin-2-yl)amino)-3-[11C]methoxyphenyl)(morpholino)methanone ([11C]HG-10-102-01) was prepared from the precursor desmethyl-HG-10-102-01 with [11C]CH3OTf through O-[11C]methylation and isolated by HPLC combined with SPE in 45–55% radiochemical yield, based on [11C]CO2 and decay corrected to end of bombardment (EOB). The radiochemical purity was >99%, and the specific activity (SA) at EOB was 370–1110 GBq/μmol with a total synthesis time of ∼40-min from EOB. | en_US |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Wang, M., Gao, M., Xu, Z., & Zheng, Q.-H. (2017). Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease. Bioorganic & Medicinal Chemistry Letters, 27(6), 1351–1355. https://doi.org/10.1016/j.bmcl.2017.02.019 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/14490 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/j.bmcl.2017.02.019 | en_US |
dc.relation.journal | Bioorganic & Medicinal Chemistry Letters | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | Author | en_US |
dc.subject | [11C]HG-10-102-01 | en_US |
dc.subject | leucine-rich repeat kinase 2 | en_US |
dc.subject | radiosynthesis | en_US |
dc.title | Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson’s disease | en_US |
dc.type | Article | en_US |